Article

The role of indoleamine 2,3-dioxygenase in stress-induced metabolic disorders

2023-03-23

Abstract excerpt

Depression is considered the second leading cause of the global health burden after cancer. Depression doubles the risk of metabolic syndrome in the overall population. Depressed people are more vulnerable to metabolic syndrome because of their poor health-related practices. The regulatory key factors between metabolic diseases and depression are poorly understood in terms of dysregulation of genes affected in dep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4d6a0ee2-169f-5608-a11e-ccfdedc09ec1
DOI: 10.21203/rs.3.rs-2713774/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The role of indoleamine 2,3-dioxygenase in stress-induced metabolic disordersDOI 10.21203/rs.3.rs-2713774/v1Read

Unraveling the Genetic Interplay and Therapeutic Potentials between Major Depressive Disorder and Metabolic Syndrome: Multi-Ancestry and Multi-Trait Genome-Wide Association AnalysesSemantic proximity Read

Blocking of carnitine palmitoyl transferase 1 potently reduces stress-induced depression in rat highlighting a pivotal role of lipid metabolism.Semantic proximity Read

Chronic Unpredictable Stress Drives Non-pathological, Adaptive Metabolic Hormone Reprogramming with Reduced Insulin Resistance Linked to Depressive-like BehaviorsSemantic proximity Read

Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networksSemantic proximity Read

Unraveling the genetic interplay and therapeutic potentials between major depressive disorder and metabolic syndrome: multi-ancestry and multi-trait genome-wide association analyses.Semantic proximity Read

Peripheral Metabolic-Redox Signaling as a Core Mechanism of Major Depressive Disorder: Evidence From Deep Metabolomic PhenotypingSemantic proximity Read

Energy metabolism in major depressive disorder: Recent advances from omics technologies and imagingSemantic proximity Read

The Metabolome-Wide Signature of Major Depressive DisorderSemantic proximity Read

Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer diseaseSemantic proximity Read

Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic ReviewSemantic proximity Read

Identification and Analysis of Key Genes Related to Metabolism in the Brain of Major Depressive DisorderSemantic proximity Read

Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.Semantic proximity Read